Date published: 2025-10-27

1-800-457-3801

SCBT Portrait Logo
Seach Input

ARP 100 (CAS 704888-90-4)

5.0(1)
Write a reviewAsk a question

See product citations (26)

Alternate Names:
ARP 100 is also known as Matrix Metalloproteinase-2 Inhibitor III.
Application:
ARP 100 is a biphenylsulfonamide and selective inhibitor of MMP-2, also capable of suppressing the invasive behavior of HT1080 tumor cells.
CAS Number:
704888-90-4
Purity:
≥98%
Molecular Weight:
364.42
Molecular Formula:
C17H20N2O5S
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

ARP 100 is a selective inhibitor of MMP-2 (IC50 = 12 nM). ARP 100 displays selectivity over MMP-9, MMP-3, MMP-1 and MMP-7 (IC50 values are 200, 4500, > 50000 and > 50000 nM respectively). ARP 100 exhibits anti-invasive properties in HT1080 fibrosarcoma cells.


ARP 100 (CAS 704888-90-4) References

  1. MMP-2 alters VEGF expression via alphaVbeta3 integrin-mediated PI3K/AKT signaling in A549 lung cancer cells.  |  Chetty, C., et al. 2010. Int J Cancer. 127: 1081-95. PMID: 20027628
  2. Tumor necrosis factor-α induces aortic intima-media thickening via perivascular adipose tissue inflammation.  |  Moe, KT., et al. 2013. J Vasc Res. 50: 228-37. PMID: 23711955
  3. Inhibitory effects of caspase inhibitors on the activity of matrix metalloproteinase-2.  |  Castro, MM., et al. 2013. Biochem Pharmacol. 86: 469-75. PMID: 23774623
  4. Matrix metalloproteinase-2 in oncostatin M-induced sarcomere degeneration in cardiomyocytes.  |  Fan, X., et al. 2016. Am J Physiol Heart Circ Physiol. 311: H183-9. PMID: 27199120
  5. Adrenomedullin promotes the growth of pancreatic ductal adenocarcinoma through recruitment of myelomonocytic cells.  |  Xu, M., et al. 2016. Oncotarget. 7: 55043-55056. PMID: 27391260
  6. Doxorubicin induces de novo expression of N-terminal-truncated matrix metalloproteinase-2 in cardiac myocytes.  |  Chan, BYH., et al. 2018. Can J Physiol Pharmacol. 96: 1238-1245. PMID: 30308129
  7. Myocardial MMP-2 contributes to SERCA2a proteolysis during cardiac ischaemia-reperfusion injury.  |  Roczkowsky, A., et al. 2020. Cardiovasc Res. 116: 1021-1031. PMID: 31373602
  8. Junctophilin-2 is a target of matrix metalloproteinase-2 in myocardial ischemia-reperfusion injury.  |  Chan, BYH., et al. 2019. Basic Res Cardiol. 114: 42. PMID: 31506724
  9. Pyridine-Containing Macrocycles Display MMP-2/9 Inhibitory Activity and Distinct Effects on Migration and Invasion of 2D and 3D Breast Cancer Models.  |  Proença, S., et al. 2019. Int J Mol Sci. 20: PMID: 31618886
  10. Matrix Metalloproteinases Repress Hypertrophic Growth in Cardiac Myocytes.  |  Euler, G., et al. 2021. Cardiovasc Drugs Ther. 35: 353-365. PMID: 33400052
  11. Staurosporine-induced cleavage of apoptosis-inducing factor in human fibrosarcoma cells is independent of matrix metalloproteinase-2.  |  Bassiouni, W., et al. 2022. Can J Physiol Pharmacol. 100: 184-191. PMID: 34597523
  12. Naringin dihydrochalcone potentially binds to catalytic domain of matrix metalloproteinase-2: molecular docking, MM-GBSA, and molecular dynamics simulation approach.  |  Singh, AK. and Kumar, S. 2022. Nat Prod Res. 1-5. PMID: 36047975
  13. The ACE Inhibitor Lisinopril Stimulates Melanoma Cell Invasiveness by Inducing MMP2 Secretion.  |  Becker, Y. and Stock, C. 2022. Cell Physiol Biochem. 56: 457-483. PMID: 36057984

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

ARP 100, 5 mg

sc-203522
5 mg
$121.00

What is the working concentration of this product for primary fibroblasts?

Asked by: Baltanas
Thank you for your question. Unfortunately we do not have this information, so we are unable to provide it for you.
Answered by: Tech Service
Date published: 2019-10-14

Has ARP100(sc-203522) been tested or shown to be effective in-vivo? If so do you know the suggested dosage and route of delivery (IV, IP, SC...etc)?

Asked by: CLab
Unfortunately we are not able to provide that information. Our compounds are not pharmaceutical grade and not manufactured under GMP guidelines. Please consult your principal investigator and your animal care and use committee (ACUC) regarding the use of our compounds.
Answered by: Technical Support
Date published: 2018-11-30

Is ARP 100 a reversible inhibitor?

Asked by: ChemSynth123
Thank you for your question. ARP 100 (CAS 704888-90-4): sc-203522 does seem to be a reversible inhibitor of matrix metalloproteinases. (Lauer-Fields, Janelle L., et al., 2008. Analytical biochemistry. 373(1): 43-51. PMID: 17949675)
Answered by: Chemical Support 7
Date published: 2020-09-30

Is sc-203522 cell-impermeable?

Asked by: Chemsynth123
Thank you for your question. ARP 100, sc-203522, is cell-permeable.
Answered by: TechService7
Date published: 2020-09-30
  • y_2025, m_10, d_14, h_6CST
  • bvseo_bulk, prod_bvqa, vn_bulk_3.0.42
  • cp_1, bvpage1
  • co_hasquestionsanswers, tq_4
  • loc_en_US, sid_203522, prod, sort_[SortEntry(order=LAST_APPROVED_ANSWER_SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getContent, 100ms
  • QUESTIONS, PRODUCT
Rated 5 out of 5 by from CastroCastro, et al. (PubMed ID 23774623) found that ARP 100 and Ac-LEHD-cmk blocked troponin I (Tnl) degradation (due to hypoxia-reoxygenation) in neonatal cardiomyocytes. -SCBT Publication Review
Date published: 2015-06-14
  • y_2025, m_10, d_14, h_6
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.42
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_203522, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getReviews, 8ms
  • REVIEWS, PRODUCT
ARP 100 is rated 5.0 out of 5 by 1.
  • y_2025, m_10, d_14, h_6
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.42
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_203522, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getAggregateRating, 102ms
  • REVIEWS, PRODUCT